SciELO - Scientific Electronic Library Online

vol.63 issue4Rotavirus in cattle: risk factors, prevalence and antigenic characterization from dairy calves' samples in São Paulo State, BrazilBone regeneration in mandible defect with autograft bone and cell suspension from bone marrow in rabbits author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links


Arquivo Brasileiro de Medicina Veterinária e Zootecnia

On-line version ISSN 1678-4162

Arq. Bras. Med. Vet. Zootec. vol.63 no.4 Belo Horizonte Aug. 2011 



Neurological disorder in cattle associated with bovine herpesvirus 4


Desordem neurológica em bovinos associada ao herpevírus bovino 4



E.A. CostaI, II; A.C. VasconcelosI; M.R.Q. BomfimI; H.B. AmorimII; G.B.L. LimaI; F.M. CoelhoI; M. ResendeII

IInstituto de Ciências Biológicas - Universidade Federal de Minas Gerais. Av. Antônio Carlos, 6627. 31270-901 - Belo Horizonte, MG
IIEscola de Veterinária - Universidade Federal de Minas Gerais - Belo Horizonte, MG




A nested PCR assay was used to diagnose bovine encephalitis through herpesviruses including bovine herpesvirus 5 (BHV-5), bovine herpesvirus 1 (BHV-1), Aujeszky's disease virus (SHV-1), and ovine herpesvirus 2 (OHV-2) in 14 fragments of central nervous system (CNS) from cattle that died with neurological signs. In addition, as some samples of bovine herpesvirus type 4 (BHV-4) have been isolated from neural tissue, it was also tested by nested PCR. The cases of encephalitis occurred in isolation at different times of the year and did not present any seasonality. The duration of the clinical course ranged between 1 to 15 days, and in 64.3% of the cases it manifested between 1 to 2 days. The most frequently observed neurological signs were ataxia, recumbency, unsteadiness and inability to stand, opisthotonus, paddling movements, nystagmus and ptyalism. In the nested assay, there was no evidence of: BHV-1, SHV-1 or OHV-2 in the DNA obtained from the CNS in any of the samples. But the presence of BHV-4 was found in all fragments of the CNS in cattle which died presenting neurological signs. Moreover, BHV-5 was found in association with BHV-4 in two of these samples.

Keywords: cattle, bovine herpesvirus 4, central nervous system, encephalitis


Nested PCR foi utilizada para o diagnóstico de encefalite bovina por herpesvírus incluindo o herpesvírus bovino 5 (BHV-5), o herpesvírus bovino 1 (BHV-1), o vírus da doença de Aujeszky (SHV-1) e o herpesvírus ovino 2 (OHV-2) em 14 fragmentos do sistema nervoso central (SNC) de bovinos que morreram com sinais neurológicos. Embora o BHV-4 não seja reconhecido como vírus neurotrófico, foi detectado nos casos de encefalite que ocorreram isoladamente em diferentes épocas do ano e não apresentaram nenhuma sazonalidade. A duração do curso clínico variou entre 1 e 15 dias, e em 64,3% dos casos manifestou-se entre 1 e 2 dias. Os sinais neurológicos mais freqüentemente observados foram ataxia, apatia, instabilidade, opistótono, movimentos de pedalagem, nistagmo e sialorréia. Nos ensaios de PCR nested realizados a partir do DNA obtido do SNC, não foi encontrado evidência de: BHV-1, SHV-1 ou OHV-2 em nenhuma das amostras. Mas, a presença de BHV-4 foi encontrada em todos os fragmentos do SNC de bovinos que morreram com sinais neurológicos. Além disso, o BHV-5 foi encontrado em associação com o BHV-4 em duas dessas amostras.

Palavras-chave: bovinos, herpesvírus bovino 4, sistema nervoso centrral, encefalite




Out of all bovine herpesviruses, the BHV-4 is the most intriguing because it is isolated in apparently healthy bovines as well as in a wide range of clinical conditions such as abortions, skin lesions, metritis, mastitis, ulcerative mammilitis, bladder and rumen tumors, cases of malignant catarrhal fever and ocular, respiratory, genital, enteric and neurological infections (Asano et al., 2003; Dewals et al., 2006).

Due to the small number of carriers, the slow reproductive cycle with low viral titer/load and slow cytopathic effect, common properties in the cytomegaloviruses (CMV), the BHV-4 was firstly grouped in the betaherpesvirus subfamily. However, because of its preference for lymphoid organs and based on its genomic structure, the BHV-4 was included in the lymphotropic herpesviruses group of the gammaherpesviruses family, Rhadinoviruses subfamily (Goyal and Naeem, 1992; Zimmermann et al., 2001).

The BHV-4 pathogenicity has not been well defined as of yet (Izumi et al., 2006). It seems that the BHV-4 infection has increased and there is a strong association between BHV-4 high antibodies loads and reproductive system infections in bovines (Goyal and Naeem, 1992). Nonetheless, experimental inoculations do not replicate the clinical disease, suggesting that the BHV-4 reactivation may be related to additional factors or conditions in order to become pathogenic (Goyal and Naeem, 1992).

It is likely that the route of the BHV-4 infection is typical of herpesviruses, which primarily replicates in the epithelial cells of the respiratory tract and presumably also in the intestinal mucous membranes (Egyed et al., 1996). After replication in epithelial cells of the respiratory tract the virus spreads to the intramucous lymph nodes and is transported to various organs of the body by infected leukocytes (Egyed et al., 1996; Zimmermann et al., 2001). High amounts of viral DNA were detected in immune system organs (spleen, tonsils, and thymus) and organs which are densely infiltrated with immune cells (kidney and intestines) suggesting that the immune cells are the main sites of replication and latency (Goyal and Naeem, 1992; Egyed et al., 1996).

Although the BHV-4 is not considered a neurotropic virus, some BHV-4 samples have been isolated in neural tissues in cases of persistent infections (Bona et al., 2005; Donofrio et al., 2005; Izumi et al., 2006) and in animals which presented neurological signs such as ataxia and encephalitis typical histopathological lesions (Fridgut and Stram., 2006; Zimmermann et al., 2001). However, it is still not very clear the direct interaction between the BHV-4 and the neurons. It is suggested, in these cases, that the nervous system is also included as a latency site, though its function in clinical and latent infections is questionable (Izumi et al., 2006).

Besides, in vitro studies showed that bovine endothelial cells were highly susceptible to BHV-4 infection (Egyed and Baska, 2003). Experimental transmission in rabbits showed that the BHV-4 is able to replicate in the cardio-vascular system tissues and is able to initiate histopathological lesions in these cells (Donofrio et al., 2005; Egyed and Baska, 2003). These lesions are only found in BHV-4 chronic infections, characterized by a local acute or chronic vasculitis, chronic endocarditic signs with accumulation of mononuclear cells (histiocytes and lymphocytes) and thrombus (Egyed and Baska, 2003).

There are BHV-4 accounts in several countries, such as the United States of America, Sweden, Germany, Belgium, South Africa, Spain, Japan and Israel. In Brazil, the studies on the presence of the BHV-4 are still scarce.

This paper reports the presence of the BHV-4 DNA in the central nervous system of cattle which died with neurological disorders in Minas Gerais State, Brazil. Furthermore, the association between the histopathological and clinical profile of these encephalitis and the BHV-4 has been described.



A total of 14 fragments of central nervous system (CNS) derived from cattle that died with neurological signs were sent to the Laboratory of Compared Virology for encephalic herpesvirus diagnosis. The survey for encephalic herpesvirus included bovine herpesvirus 5 (BHV-5), bovine herpesvirus 1 (BHV-1), Aujeszky's disease virus (SHV-1), and ovine herpesvirus 2 (OHV-2) using PCR assays. In addition, the bovine herpesvirus 4 (BHV-4) DNA was also tested, although is not considered a neurotropic virus.

These samples had been previously submitted to direct immunofluorescence (IF) and mice inoculation (MI) tests and all samples tested were negative for rabies. These cases occurred in 2005. Age, gender, breed, kind of production (dairy, beef breeds or crossbred), clinical history, duration and extension of clinical signs of each animal were recorded in a questionnaire by attending veterinarians and owners. Fragments of the CNS were usually sent frozen and were stored at -20ºC. Repeated freezing and thawing of samples was avoided.

For the DNA recovery, 1.0g was used from fragments of CNS homogenized in a 500μl sodium iodide (6M NaI) solution. One aliquot of 100μl was used for DNA extraction through the silica procedure (Boom et al., 1990). One microliter (200ng) of DNA was used as a template for each PCR. An internal control of the amplification efficiency was used in a separate PCR assay with primers for the highly conserved mammalian insulin-like growth factor 1 (IGF-1) gene (Mikawa et al., 1995). In samples which failed to amplify this gene, the DNA extraction and PCR were repeated. Positive control for each PCR was included in every test, which consisted of purified DNA as follows: BHV-5, strain EVI-88 (Spilki et al., 2002); SHV-1, strain A031 (Flatschart and Resende, 2001); OHV-2, strain F1 (Andrade et al., 2006). In all field samples internal control (IGF-1) gene was used. In addition, as negative control, water was used for each PCR assay. The PCR assay for each virus was performed as described in Table 1.



The amplified products were analyzed by electrophoresis in 2% agarose gels by using 0.5 X Tris-borate-EDTA as the running buffer. The ethidium bromide-stained bands were visualized with UV light. The molecular size of the fragments was compared with those of a 100-bp DNA ladder molecular marker (Invitrogen Corp., Carlsbad, CA).

The identity of the PCR product was confirmed by the sequencing of four amplicons randomly chosen from the sampling total. PCR products were purified using the PureLink PCR kit (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions and submitted to nucleotide sequencing in a MEGABACE sequencer (Amersham Biosciences). The nested PCR products were sequenced three times in both orientations by the dideoxy method using ET Dynamic Terminator for MEGABACE (GE Healthcare, Fairfield, CT, USA). The nucleotide (nt) sequences of BHV-4 thymidine kinase partial gene were assembled using the CAP3 Sequence..., (CAP3..., 2006) ( and deposited in GenBank under accession numbers EU244697 (MGArom), EU244698 (MGA696), EU244699 (MGA514), EU244700 (MGA1075). These nucleotide sequences and inferred amino acid sequences were aligned and compared with BHV-4 sequences in GenBank using the ClustalW 1.6 program (Thompson et al., 1994).

Fragments of CNS fixed in 10% neutral formalin were processed routinely and embedded in paraffin, and 5μm thick sections were cut and stained with hematoxylin and eosin for histological examination (Luna, 1968).



The BHV-4 sequences were identified by PCR in all samples of the CNS analyzed. There was no detection of BHV-1, SHV-1 e AHV-1 in the DNA extracted from the SNC in any of the analyzed animals. Out of the samples positive for BHV-4, two were positive for BHV-5. The internal control was amplified by PCR in all fourteen clinical samples included in this study. The use of primers for mammalian IGF-1 gene was important in the detection of false negatives or invalid results.

The translation of the sequences obtained by PCR assay is part of the open reading frame 2 (ORF 2) of the thymidine kinase gene. This ORF 2 is homologous to the gammaherpesvirus Epstein-Barr virus (EBV) BXRF1 gene (Lomonte et al., 1992). All four BHV-4 thymidine kinase partial sequences were closely related to each other. The identity ranged between 94 to 100% at the deduced amino acid sequence level and between 96 to 99% at the nucleotide sequence level. By comparison with homologous sequences of BHV-4 isolates available in the GenBank, the highest identity degree at nucleotide and deduced amino acid sequence levels was observed in sequences S49773, AB035515, AB035516 and AB035517. The variation identity among homologous sequences ranged between 91 to 98% and 95 to 99% at the deduced amino acid and nucleotide sequence levels, respectively.

Additionally, the Brazilian strain MGA696 (EU244698) presented 3-nt deletion corresponding to nt 529-531 (based on GenBank PubMed Protein Query accession number AAB24378), causing the loss of 1 lysine (K). This characteristic was not observed in any other BHV-4 homologous sequence. The MGArom (EU244697), MGA696 (EU244698) and MGA1075 (EU244700) sequence strains exhibited 1 amino acid substitution (threonine to proline) when compared to the S49773 sequence (position 388 to 390). Moreover, the MGArom strain sequence (EU244697) also exhibited 1 amino acid substitution (proline to serine) when compared to the same sequence (position 397 to 399).

Due to the lack of material preserved in formalin, the encephalon histological evaluation was performed in six out of the fourteen BHV-4 cases. In all cases a non suppurative encephalitis was observed, affecting the cerebellum and the brain, also extending to the meningis, with intense hyperemia (Fig. 1A) and mononuclear infiltrates (lymphocytes and monocytes, predominantly) within the meningis and filling the Virchow-Robin perivascular spaces (perivascular cuffing) (Fig. 1B). In 5 of these samples a degeneration of the nervous tissue such as gliosis, neuronophagia, and darkened shrunk neurons was observed (Fig. 1C), sometimes with vascular lesions such as congestion, focal hemorrhage (Fig. 1D) and thrombosis.

The neurological signs reported by veterinarians and owners, in decreasing order of frequency, were ataxia (12/14 - 85.7%), recumbency (8/12 - 57,1%), inability to stand (7/14 - 50,0%), restlessness (6/14 - 42,9%), opisthotonus (5/14 - 35,7%), paddling movements (4/14 - 28,6%), nystagmus (4/14 - 28,6%), ptyalism (4/14 - 28,6%) and unsteadiness on standing position (4/14 - 28,6%). The development of the neurological signs in the affected bovines ranged between 1 to 15 days and in 64.3% (9/14) of the cases it was manifested between 1 to 4 days. Bovines of both genders were affected and females comprised 85.7% (12/14) of the cases. The age of the affected bovines ranged from 3 months to 7 years, and 50% (7/14) of the animals were 2-year-olds.

In most properties (10/14 - 71.4%) the neurological disease was sporadic, affecting one to four bovines per herd, and in four properties (28.6%) 6 to 30 bovines were affected. The BHV-4 cases did not present a seasonal character. However, as in these cases only one animal was sent to diagnosis, it was not possible to ascertain that there was an association between the neurological disease and the BHV-4 in all bovines from these herds.

In two properties, besides the neurological signs, the animals presented respiratory symptoms such as coughing, breathlessness and dyspnea. According to information given by the owners and responsible veterinarians, during the necropsy it was found that the bovine's lungs were 60% congested. In these two properties, a serological examination for the bovine respiratory syncytial virus (BRSV) showed evidence of seropositive animals. In addition, in all properties affected by the BHV-4, mastitis cases and reproductive disorders were frequently observed.



Bovine herpesvirus 4 (BHV-4) is one of the four bovine herpesviruses that occur worldwide. BHV-1, BHV-2 and BHV-5 are responsible for infectious bovine rhinotracheitis-pustular vulvovaginitis, bovine herpesvirus mammilitis and bovine encephalitis herpesvirus, respectively (Lomonte et al., 1992). Even though the BHV-5 is the bovine herpesvirus causative of encephalitis, cases of neurological disorders and encephalitis in bovines infected with the BHV-1 and BHV-4, despite being less frequent, have been reported (Yamamoto et al., 2000; Spilki et al., 2002; Fridgut and Stram, 2006).

In all BHV-4 cases detected in this study, derived from CNS samples of bovines which died after presenting neurological signs, non-suppurative encephalitis was observed in the histopathologically analyzed encephala. However, the BHV-4 function in the nervous system is still obscure. Conversely to the other herpesviruses, it was not possible to prove that the BHV-4 is the causative agent of any diagnosed disease (Fridgut and Stram, 2006), especially neurological disorders.

The genomic structure, the gene arrangement and the biological properties confirm that BHV-4 belongs to the genus Rhadinovirus (Zimmermann et al., 2001). According to the analysis of the LUR regions outside the conserved gene blocks from many BHV-4 strains, the existence of DNA insertions or deletions in homologous sequences give evidence of significant strain differences with consequences on the ORFs (Zimmermann et al., 2001). As the BHV-4 strains represent a heterologous group of viruses, it is possible that different strains vary in their biological properties, including cellular tropism and latency sites leading to a variety of clinical disorders, likely, in their capacity, to invade the nervous system (Asano et al., 2003; Egyed and Baskas, 2003).

The majority of Alphaherpesviruses avoid their elimination by the host immune system through latency within the nervous system cells, such as the ganglia, between the disease episodes. On the other hand, the Beta and Gammaherpesviruses avoid their elimination through latency within the lymphocytes. Blood samples in EDTA tubes for the BHV-4 detection in the leukocytes (PBL), as well as the bovines' encephala, were collected in only property in this study. In this case, the BHV-4 was detected in both specimens, proving that the virus was associated to the CNS and the leukocytes. Besides, the BHV-4 presence in the leukocytes of the dead calves' mothers suggests that they are the virus transmission source, since the virus can be found and can multiply in the mammary epithelium and in leukocytes present in the milk (Wellenberg et al., 2002).

In the other cases, only the association to the CNS was confirmed. When the BHV-4 DNA is found in the nervous system and in lymphocytes, it is suggested that the BHV-4 is latent in both tissues (Yamamoto et al., 2000). However, there are reports of BHV-4 latent in only one of these sites (Izumi et al., 2006).

Several gammaherpesviruses are associated to lymphoproliferative diseases and tumor development. These diseases seem to be associated to immunosuppression or a late-in-life infection of the natural host as well as with the infection of a related non-natural host. There is no established link between the BHV-4 and such diseases (Zimmermann et al., 2001). Gammaherpesvirus genes homologous to cellular genes have been demonstrated to be often involved in cell growth or cell survival, in the nucleotide metabolism and in immune escape. The set of such genes in the BHV-4 is reduced when compared to other gammaherpesviruses with known transforming capacity. In conclusion, the possibility that BHV-4 has a lymphoproliferative or transforming capacity under certain conditions cannot be excluded, but there is no evidence that this virus has the genes required to cause such diseases (Egyed et al., 1996; Zimmermann et al., 2001). Meanwhile, for the occurrence of any clinical manifestation of the BHV-4, an association with bacteria, fungi or another virus may be necessary (Goyal and Naeem, 1992; Fridgut and Stram, 2006). Studies reveal that in approximately 75% of the BHV-4 infection cases where there was a clinical manifestation of any disease, the animals were co-infected by other pathological agents (Goyal and Naeem, 1992).

Two co-infection cases of the BHV-4 with the BHV-5 were found in this study and in two properties the bovines were seropositive for the bovine respiratory syncytial virus (BRSV). It is worth pointing out that the BHV-5 is a causative agent of encephalitis in bovines. In the BRSV co-infection cases the calves not only presented neurological signs, but also respiratory symptoms similar to the ones occurred in BRSV infections. Additional diagnostics for bacteria or fungi were not performed in any BHV-4 cases.

The BHV-4 is present in the bovine population at rates which vary according to the region and it can be activated when the animals are exposed to some kind of stress, such as long distance transportation, parturition, sudden climate changes and dexamethasone treatments (Izumi et al., 2006). In the case of samples where the BHV-4 is latent in the nervous system, the virus activation by stress induced immunosuppression may result in a replication in the latency site and it might lead to a neurological disease. Studies reveal that though the blood lymphocytes are one of the BHV-4 latency sites, the virus replication occurs in them during the first seven weeks of the infection, and the number of infected cells is much larger from 2 to 5 weeks (Egyed et al., 1996). However, a neurological disorder in bovines infected with BHV-4 may not be related to its presence in the nervous system (Yamamoto et al., 2000).

Studies have shown that the BHV-4 is able to replicate and initiate histopathological lesions in the vascular system cells of experimentally infected rabbits and that endothelial cells cultures are a 100 to a 1000 times more sensitive to the BHV-4 than the other cells normally used for viral isolation such as the Madin Darby Bovine Kidney (MDBK) continuous lineage cells (Goyal and Naeem, 2002; Egyed and Baska, 2003). On account of the tropism for endothelial cells and because it causes vascular lesions in mammals, another hypothesis for the encephalitis in some bovines infected by the BHV-4 would be the virus replication in the nervous system endothelial cells, causing an inflammatory reaction through the vascular damages. That would explain the fact that in this study some of the BHV-4 infected bovines presented encephalitis with notable vascular lesions such as hemorrhages, thrombus and lymphocytic vasculitis. It could be that the tropism for lymphoid and epithelial cells of some of the BHV-4 samples, results in histopathological signs similar to the malignant catarrhal fever, in which a generalized lymphoid vasculitis is always observed (Goyal and Naeem, 1992; Asano et al., 2003).

The BHV-4 is disseminated worldwide among bovine populations, especially in North America, Japan, Hungary, Thailand, Israel and some other European countries (Egyed and Baska, 2003; Fridgut and Stram, 2006; Izumi et al., 2006). In the present study, the BHV-4 cases were reported in seven of the ten administrative regions of Minas Gerais, therefore spread throughout the whole State. In Minas Gerais the majority of properties have animals showing problems with mastitis, reproductive disorders and abortions, including the properties where the BHV-4 was detected. Because these diseases involve several causative agents, it is very difficult to establish the diagnosis. As the BHV-4 is frequently associated to these diseases, it is possible to include it as a probable aggravating factor, together with other causative agents, since the reports indicate that outbreaks of diseases involving BHV-4 result from multifactorial processes (Fridgut and Stram, 2006). Nonetheless, a serological research in the bovine population should be carried out to verify the prevalence of the BHV-4 in Minas Gerais. However, the BHV-4 associated with encephalitis appears to be a sporadic event and it does not mean that it is the cause of neurological diseases or other diseases such as abortions and mastitis outbreaks (Fridgut and Stram, 2006).



In all cases of non-suppurated BHV-4, DNA was detected in 14 samples. In two samples BHV-5 DNA was also detected. These samples were negative for rabies virus, BHV-1, OHV-2 and SHV-1 genome. In 12 cases of encephalitis, only BHV-4 was detected.



We thank the veterinary practitioners who have participated in this study and the farm owner. This study was supported by CNPq grant 474015/2001-7. Erica A. Costa and Maria Rosa Q. Bomfim received scholarship from FAPEMIG.



ANDRADE, E.H.P.; RESENDE, M.; COSTA, E.A. et al. Análise filogenética do herpesvírus ovino tipo 2. In: SEMANA DE INICIAÇÃO CIENTÍFICA, 15., 2006. Belo Horizonte, MG. Trabalhos apresentados... Belo Horizonte: UFMG, 2006.         [ Links ]

ASANO, A.; INOSHIMA, Y.; MURAKAMI K. et al. Latency and persistence of bovine herpesvirus type 4 strain B11-41 in bovine nervous tissues. Virology, v.65, p.87-93, 2003.         [ Links ]

BAXTER S.I., POW I., BRIDGEN A. et al. PCR detection of the sheep-associated agent of malignant catarrhal fever. Arch. Virol., v.132, p.145-159, 1993.         [ Links ]

BONA, C.; DEWALS B.; WIGGERS, L. et al. Short communication: pasteurization of milk abolishes bovine herpesvirus 4 infectivity. J. Dairy Sci., v.88, p.3079-3083, 2005.         [ Links ]

BOOM, R.; SOL C.J.; SALIMANS, M.M. et al. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol., v.28, p.495-503, 1990.         [ Links ]

DEWALS, B.; THIRION, M.; MARKINE-GORIAYNOFF, N. et al. Evolution of bovine herpesvirus 4: recombination and transmission between Africa buffalo and cattle. J. Gen. Virol,. v.87, p.1509-1519, 2006.         [ Links ]

DONOFRIO, G.; CAVIRANI, S.; VAN SANTEN, V. et al. Potential secundary pathogenic role for bovine herpesvirus 4. J. Clin. Microbiol., v.43, p.3421-3426, 2005.         [ Links ]

EGYED, L.; BALLAGI-PORDÁNY, A.; BARTHA, A. et al. Studies of in vivo distribution of bovine herpesvírus type 4 in the natural host. J. Clin. Microbiol., v.34, p.1091-1095, 1996.         [ Links ]

EGYED, L.; BASKA, F. Histological lesions in vascular tissues of bovine herpes virus type 4-infected rabbits. Vet. Microbiol., v.91, p.1-10, 2003.         [ Links ]

FLATSCHART, R.B.; RESENDE, M. Acute and latent infection in mice with a virulent strain of Aujeszky's disease virus. Braz. J. Microbiol., v.3, p.308-311, 2001.         [ Links ]

FRIDGUT, O.; STRAM, Y. Bovine herpesvirus 4 in Israeli dairy cattle: isolation PCR and serology. Israel J. Vet. Med., v.61, p.56-59, 2006.         [ Links ]

GOYAL, S.M.; NAEEM, K. Bovid herpesvirus-4: a review. Vet. Bull., v.62, p.181-201, 1992.         [ Links ]

IZUMI, Y.; TSUDUKU, S.; MURAKAMI, K. et al. Characterization of bovine herpesvirus type 4 isolated from cattle with mastitis and subclinical infection by the virus among cattle. Virology, v.68, p.189-193, 2006.         [ Links ]

LOMONTE, P.; BUBLOT, M.; PASTORET, P.-P. et al. Location and characterization of the bovine herpesvirus type 4 thymidine kinase gene, comparison with thymidine kinase genes of other herpesviruses. Arch. Virol., v.127, p.327-337, 1992.         [ Links ]

LUNA, L.G. Manual of histologic staining methods of the armed forces institute of pathology. New York: McGraw-Hill, 1968. 258p.         [ Links ]

MIKAWA, S.; YOSHIKAWA, G.; AOKI, H. et al. Dynamic aspects in the expression of the goat insulin-like growth factor-1 (IGF-1) gene: diversity in transcription and post-transcription. Biosc. Biotech. Biochem., v.59, p.87-92, 1995.         [ Links ]

SCHERBA, G.; JIN L.; SCHNITZLEIN, W.M. et al. Differential polymerase chain reaction for detection of wild-type and a vaccine strain of Aujeszky's disease (pseudorabies) virus. J. Virol. Methods, v. 38, p. 131-144, 1992.         [ Links ]

SEQUENCE assembling Program (CAP3). Available from <> Accessed in: 22 May 2006.         [ Links ]

SPILKI, F.R.; ESTEVES, P.A.; FRANCO, A.C. et al. Neurovirulência e neuroinvasividade de herpesvírus bovinos tipos 1 e 5 em coelhos. Pesqui. Vet. Bras., v.22, p.58-63, 2002.         [ Links ]

THOMPSON, J.D.; HIGGINS, D.G.; GIBSON, T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucleic Acids Res., v.22, p.4673-4680, 1994.         [ Links ]

WELLENBERG, G.J.; BRUSCHKE, C.J.M.; WISSELINK, H.J. et al. Simultaneous intramammary and intranasal inoculation of lactating cows with bovine herpesvirus 4 induce subclinical mastitis. Vet. Microbiol., v.86, p.115-129, 2002.         [ Links ]

YAMAMOTO, Y.; MURAKAMI, K.; NAKANE T. et al. Characterization of a bovine herpesvirus type 4 isolated from the spinal cord of a cow with astasia. Arch. Virol., v.145, p.2363-2370, 2000.         [ Links ]

ZIMMERMANN, W.; BROLL, H.; EHLERS, B. et al. Genome sequence of bovine herpesvirus 4 a bovine Rhadinovirus and identification of an origin of DNA replication. J. Virol. v.75, p.1186-1194, 2001.         [ Links ]



Recebido em 10 de junho de 2010
Aceito em 6 de maio de 2011

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License